scholarly journals Mycophenolate mofetil‐induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case report

2021 ◽  
Vol 9 (12) ◽  
Author(s):  
Minoo Moghimi ◽  
Zahra Nekoukar ◽  
Farhad Gholami
Keyword(s):  
Mycophenolate Mofetil ◽  
Case Report ◽  
Peripheral Neuropathy ◽  
Membranous Glomerulonephropathy

scholarly journals Mycophenolate Mofetil-Induced Peripheral Neuropathy In The Treatment of Membranous Glomerulonephropathy: A Case Report

2021 ◽  
Author(s):  
Minoo Moghimi ◽  
Zahra Nekoukar ◽  
ّFarhad Gholami
Keyword(s):  
Mycophenolate Mofetil ◽  
Case Report ◽  
Peripheral Neuropathy ◽  
Immunosuppressive Agent ◽  
Axonal Polyneuropathy ◽  
Sensory Motor ◽  
Membranous Glomerulonephropathy

Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we describe a 66-year-old male MGN case treated with MMF and revealed acquired sensory-motor axonal polyneuropathy, which is rare and has not been reported before.

Peripheral Neuropathy in a Patient with Churg-Strauss Syndrome - A case report -

2007 ◽  
Vol 20 (2) ◽  
pp. 208
Author(s):  
Jun Hwa Lee ◽  
Jeong Hyun Lee ◽  
Young Kwon Go ◽  
Won Hyung Lee
Keyword(s):  
Case Report ◽  
Peripheral Neuropathy ◽  
Churg Strauss Syndrome ◽  
Strauss Syndrome ◽  
Churg Strauss

Mycophenolate mofetil combined with corticosteroids in treatment of idiopathic retroperitoneal fibrosis:a case report

2011 ◽  
Vol 31 (2) ◽  
pp. 230-231
Author(s):  
Zhen-hua CUI ◽  
Ying-shun JIN ◽  
Ying-li HONG ◽  
Ying CHEN ◽  
Can LI
Keyword(s):  
Mycophenolate Mofetil ◽  
Case Report

CIGUATERA AND PERIPHERAL NEUROPATHY: A CASE REPORT

2000 ◽  
Vol 5 (4) ◽  
pp. 250-251 ◽  
Author(s):  
F Derouiche ◽  
E Cohen ◽  
G Rodier ◽  
C Boulay ◽  
S. Courtois
Keyword(s):  
Case Report ◽  
Peripheral Neuropathy

Coeliac Disease Associated with Peripheral Neuropathy in a Child: A Case Report

1998 ◽  
Vol 29 (3) ◽  
pp. 155-158 ◽  
Author(s):  
A. Simonati ◽  
P. Battistella ◽  
C. Guariso ◽  
M. Clementi ◽  
N. Rizzuto
Keyword(s):  
Case Report ◽  
Peripheral Neuropathy ◽  
Coeliac Disease

MR angiography for the evaluation of non-systemic vasculitic neuropathy: A case report

2003 ◽  
Vol 44 (3) ◽  
pp. 316-318
Author(s):  
M. Sanada ◽  
M. Terada ◽  
E. Suzuki ◽  
A. Kashiwagi ◽  
H. Yasuda
Keyword(s):  
Case Report ◽  
Peripheral Neuropathy ◽  
Mr Angiography ◽  
The State ◽  
Vascular Lesions ◽  
Vascular Involvement ◽  
Vasculitic Neuropathy ◽  
Small Arteries

Peripheral neuropathy due to vasculitis without any complications of vasculitis in other organs was first reported in 1987. This condition was termed non-systemic vasculitic neuropathy (NSVN). Although vasculitis is believed to develop in small arteries and arterioles in this disease, the level of vascular involvement has not been fully established. We present a case of NSVN followed up by MR angiography, which was thought to be useful to assess the level as well as the state of vascular lesions in this condition.

scholarly journals Gelsolin Familial Amyloidosis Peripheral Neuropathy in Canada: A Case Report

2015 ◽  
Vol 42 (5) ◽  
pp. 353-355 ◽  
Author(s):  
Majed Alabdali ◽  
Carolina Barnett ◽  
Alon Abraham ◽  
Danah Al Jaafari ◽  
Vera Bril
Keyword(s):  
Case Report ◽  
Peripheral Neuropathy

Acquired Pelger-Huët Anomaly in Association With Concomitant Tacrolimus and Mycophenolate Mofetil in a Liver Transplant Patient: A Case Report and Review of the Literature

2006 ◽  
Vol 130 (1) ◽  
pp. 93-96
Author(s):  
Joan E. Etzell ◽  
Endi Wang
Keyword(s):  
Liver Transplantation ◽  
Mycophenolate Mofetil ◽  
Case Report ◽  
Transplant Patient ◽  
Immunosuppressive Agents ◽  
Single Agent ◽  
Review Of The Literature ◽  
Liver Transplant Patient ◽  
Underlying Causes ◽  
Nuclear Segmentation

Abstract Pelger-Huët anomaly is a congenital or acquired abnormality of neutrophil nuclear segmentation. The acquired form may be a result of a clonal myeloid malignancy, such as myelodysplastic syndrome, or may be a secondary nonclonal change related to a variety of underlying causes, including infections and medications. We report a case of a 56-year-old man who developed acquired Pelger-Huët anomaly following liver transplantation while on the immunosuppressive agents tacrolimus and mycophenolate mofetil. These medications have been reported in association with this abnormality, but usually as a single agent or in combination with other drugs. In our case, the Pelger-Huët anomaly may be the result of the combination of these 2 drugs or mycophenolate alone with subsequent desensitization because resolution of the abnormality occurred after a reduction in mycophenolate mofetil dose, and the abnormality did not recur when mycophenolate mofetil was increased to a dose previously associated with Pelger-Huët anomaly during the time that tacrolimus was discontinued.

scholarly journals Spinal Cord Stimulation as a Treatment Option for Refractory Chemotherapy-Induced Peripheral Neuropathy: Case Report

2020 ◽  
Vol 39 (03) ◽  
pp. 228-231 ◽  
Author(s):  
Arthur Lopes ◽  
Kleber Duarte ◽  
Catarina Lins ◽  
Gabriel Kubota ◽  
Valquíria Silva ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Spinal Cord ◽  
Neuropathic Pain ◽  
Case Report ◽  
Peripheral Neuropathy ◽  
Treatment Option ◽  
Spinal Cord Stimulation ◽  
Lower Limbs ◽  
Oncological Diseases ◽  
Good Treatment Option

AbstractColorectal cancer is one of the most common oncological diseases. Chemotherapy is usually recommended as an adjuvant treatment for stage-II, -III, and -IV tumors. Approximately 10% of the patients develop neuropathic pain after chemotherapy, and they may remain refractory despite the administration of drugs that are commonly used to treat neuropathic pain. Spinal cord stimulation is a good treatment option for neuropathic pain of the lower limbs, and it should be trialed in patients with chemotherapy-induced peripheral neuropathy. We report the case of a patient with oxaliplatin-induced neuropathy and neuropathic pain refractory to oral medication who was successfully treated by spinal cord stimulation.

Sign in / Sign up

Export Citation Format

Share Document